Small-molecule inhibitors against MEK/ERK strongly alleviate the wasting effects in yki-tumor-bearing flies, as well as C26-tumor cell models, providing pharmaceutical opportunities in prevention and treatment of cancer-associated cachexia (Song et al., 2019). The gene discussed is MAP2K7; the disease is neoplasm.